- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Polynovo Ltd (PNV)
Polynovo Ltd stock price live, this page displays ASX PNV stock exchange data. View the PNV premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Polynovo Ltd real time stock price chart below.
What Is the Polynovo Ltd Stock Price Today?
The Polynovo Ltd stock price today is 1.040.
What Is the Stock Symbol for Polynovo Ltd?
The stock symbol for Polynovo Ltd is "PNV."
What Stock Exchange Does Polynovo Ltd Trade On?
Polynovo Ltd is listed and trades on the Sydney stock exchange.
Is Polynovo Ltd a Good Stock to Buy?
Determining whether Polynovo Ltd, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PNV quote. (ISIN: AU000000PNV0)
What Is the Polynovo Ltd Stock Price Today?
The Polynovo Ltd stock price today is 1.040.
What Is the Stock Symbol for Polynovo Ltd?
The stock symbol for Polynovo Ltd is "PNV."
What Stock Exchange Does Polynovo Ltd Trade On?
Polynovo Ltd is listed and trades on the Sydney stock exchange.
Is Polynovo Ltd a Good Stock to Buy?
Determining whether Polynovo Ltd, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PNV quote. (ISIN: AU000000PNV0)
1.040
+0.010(+0.97%)
Closed·
Fair Value
An estimate of a Polynovo's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.013
1.090
52 wk Range
0.810
1.665
PNV is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Polynovo's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.0131.090
52 wk Range
0.8101.665
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
PNV Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Polynovo's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
1.297
Upside
+24.74%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Cash flows can sufficiently cover interest payments
Calzada receives Investment Bank Analyst Rating Update- Investing.com
Pro
Calzada receives Investment Bank Analyst Rating Update- Investing.com
Pro
- Calzada receives Investment Bank Analyst Rating Update
- Investing.com
Pro 
Calzada receives Investment Bank Analyst Rating Update- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Sell
Moving Averages
Strong Buy
Analyst Ratings
6 Buy
2 Hold
0 Sell
Ratings:
8 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 1.297
(+24.74% Upside)
Polynovo Ltd Earnings Call Summary for H2/2026
- PolyNovo reported FY 2026 sales of AUD 138M (up 16.7% reported, 21.3% constant currency) with adjusted EBITDA rising 50% to AUD 13.4M.
- U.S. sales reached AUD 102M with 200 new hospital accounts added; NovoSorb MTX sales nearly doubled to AUD 12.6M from AUD 6.7M prior year.
- Operating cash flow surged to AUD 23.1M from AUD 3.1M; gross margin held at 89%, expected to remain 90-95% until new facility impacts margins.
- Company targets PMA submission by end of calendar 2027 with 12-month FDA review expected; SynPath U.S. launch planned for FY 2027 with HCPCS code secured.
- Shares fell 8% to $0.975 despite strong results, reflecting investor concerns about execution risk, lumpy burn demand, and competitive pressures in wound care.
Last Updated: 26/08/2026, 02:44
Read Full TranscriptEarnings
Latest Release
Aug 25, 2026
EPS / Forecast
0.01 / --
Revenue / Forecast
79.52M / 83M
Compare PNV to Peers and Sector
Metrics to compare | PNV | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipPNVPeersSector | |
|---|---|---|---|---|
P/E Ratio | 97.9x | −1.5x | −0.4x | |
PEG Ratio | −2.20 | −0.03 | 0.00 | |
Price/Book | 7.9x | 2.1x | 2.6x | |
Price / LTM Sales | 4.8x | 1.7x | 3.1x | |
Upside (Analyst Target) | 15.8% | 94.4% | 48.2% | |
Fair Value Upside | Unlock | 20.3% | 6.5% | Unlock |
PolyNovo Limited designs, manufactures, and sells biodegradable medical devices in Australia, New Zealand, the United States, the United Kingdom, Ireland, Singapore, India, Hong Kong, and China. The company offers NovoSorb Biodegradable Temporising Matrix, a dermal matrix for the regeneration of the dermis when lost through extensive surgery, trauma, or burn; NovoSorb MTX for burns, chronic, trauma, and surgical wounds; and hernia repair, plastics and reconstructive device products. The company was formerly known as Calzada Limited and changed its name to PolyNovo Limited in November 2014. PolyNovo Limited was incorporated in 1998 and is headquartered in Port Melbourne, Australia.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Polynovo (PNV) Stock Price Today?
The Polynovo stock price today is 1.040 AUD.
What Stock Exchange Does Polynovo Trade On?
Polynovo is listed and trades on the Sydney Stock Exchange.
What Is the Stock Symbol for Polynovo?
The stock symbol for Polynovo is "PNV."
What Is the Polynovo Market Cap?
As of today, Polynovo market cap is 718.480M AUD.
What Is Polynovo's Earnings Per Share (TTM)?
The Polynovo EPS (TTM) is 0.011.
When Is the Next Polynovo Earnings Date?
Polynovo will release its next earnings report on Aug 21, 2026.
From a Technical Analysis Perspective, Is PNV a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Polynovo Stock Split?
Polynovo has split 0 times.
How Many Employees Does Polynovo Have?
Polynovo has 301 employees.
What is the current trading status of Polynovo (PNV)?
As of Aug 29, 2026, Polynovo (PNV) is trading at a price of 1.040 AUD, with a previous close of 1.030 AUD. The stock has fluctuated within a day range of 1.013 AUD to 1.090 AUD, while its 52-week range spans from 0.810 AUD to 1.665 AUD.
What Is Polynovo (PNV) Price Target According to Analysts?
The average 12-month price target for Polynovo is 1.297 AUD, with a high estimate of 2.1 AUD and a low estimate of 0.95 AUD. 6 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +24.74% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.